Join
Live feed
·
INSIDERFilingvia Quantisnow
F-star Therapeutics Inc. logo

SEC Form 4: Kayitalire Louis sold $437 worth of shares (64 units at $6.83) as part of a pre-agreed trading plan, decreasing direct ownership by 0.12% to 54,255 units

ByQuantisnow·Wall Street's wire, on your screen.
FSTX· F-star Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FSTX (F-star Therapeutics Inc.) and more on Quantisnow.